{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cholic acid", "Liraglutide", "Oral", "Rhamnolipids", "Type 2 diabetes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36647125", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "16"}], "Language": ["eng"], "ELocationID": ["16", "10.1186/s12951-022-01743-9"], "Journal": {"ISSN": "1477-3155", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan", "Day": "16"}}, "Title": "Journal of nanobiotechnology", "ISOAbbreviation": "J Nanobiotechnology"}, "ArticleTitle": "Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery.", "Pagination": {"StartPage": "16", "MedlinePgn": "16"}, "Abstract": {"AbstractText": ["Oral administration offered a painless way and improved compliance for diabetics. However, the emerging GLP-1 analog peptide drugs for diabetes primarily rely on the injection route, and the development of oral dosage forms was hampered by the low oral bioavailability due to the structural vulnerability to digestive enzymes and molecule impermeability in the gastrointestinal tract.", "In this study, the non-covalent interaction between cholic acid (CA) and liraglutide (LIRA) was found and theoretically explained by molecular docking simulation. Formation of this physical complex of liraglutide and cholic acid (LIRA/CA Complex) reduced the self-aggregation of LIRA and accelerated intestinal epithelium penetration. By the anti-solvent method, LIRA/CA Complex was loaded into zein/rhamnolipids nanoparticles (LIRA/CA@Zein/RLs) with a loading efficiency of 76.8%. LIRA was protected from fast enzymatic degradation by the hydrophobic zein component. Meanwhile, Rhamnolipids, a glycolipid with surface activity, promoted endocytosis while also stabilizing the nanoparticles. The two components worked synergistically to ensure the delivery of LIRA/CA Complex to intestinal villi and improved oral absorption without disrupting tight junctions. LIRA/CA@Zein/RLs demonstrated a considerable intestinal epithelium absorption in mouse gastrointestinal section and a retention in vivo\u00a0over 24 h, resulting in a significant and long-lasting hypoglycemic effect in Type 2 diabetes mice.", "This study provided a promising oral delivery approach for LIRA and exhibited the potential for further translation into clinical application."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China."}], "LastName": "Bao", "ForeName": "Xiaoyan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai, 201203, China."}], "LastName": "Qian", "ForeName": "Kang", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China."}], "LastName": "Xu", "ForeName": "Mengjiao", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}], "LastName": "Chen", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China."}], "LastName": "Wang", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China."}], "LastName": "Pan", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China."}], "LastName": "Wang", "ForeName": "Zhengyi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Center of Polymers and Polymer Composite Materials, Department of Macromolecular Science, Fudan University, 2005 Songhu Road, Shanghai, 200438, China. yaoping@fudan.edu.cn."}], "LastName": "Yao", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Wenzhou Medical University, Gaojiao Zone, Wenzhou, 325035, China. linliwz@163.com."}], "LastName": "Lin", "ForeName": "Li", "Initials": "L"}], "GrantList": [{"GrantID": "LQ22H302557", "Agency": "Natural Science Foundation of Zhejiang Province", "Country": ""}, {"GrantID": "Y20210210", "Agency": "Medical and Health Science Project of Wenzhou City", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Nanobiotechnology", "NlmUniqueID": "101152208", "ISSNLinking": "1477-3155"}, "ChemicalList": [{"RegistryNumber": "839I73S42A", "NameOfSubstance": "Liraglutide"}, {"RegistryNumber": "9010-66-6", "NameOfSubstance": "Zein"}, {"RegistryNumber": "0", "NameOfSubstance": "rhamnolipid"}, {"RegistryNumber": "G1JO7801AE", "NameOfSubstance": "Cholic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycolipids"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Liraglutide"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["chemistry"], "DescriptorName": "Zein"}, {"QualifierName": [], "DescriptorName": "Cholic Acid"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Glycolipids"}, {"QualifierName": [], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": [], "DescriptorName": "Nanocomposites"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "International diabetes federation. IDF diabetes atalas 10th edition. 2022.\u00a0https://diabetesatlas.org/atlas/tenth-edition/. Accessed on 15 October, 2022."}, {"Citation": "American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(Suppl 1):37\u201342. doi: 10.2337/diacare.28.suppl_1.S37.", "ArticleIdList": ["10.2337/diacare.28.suppl_1.S37", "15618111"]}, {"Citation": "Dowarah J, Singh VP. Anti-diabetic drugs recent approaches and advancements. Bioorg Med Chem. 2020;28:115263. doi: 10.1016/j.bmc.2019.115263.", "ArticleIdList": ["10.1016/j.bmc.2019.115263", "32008883"]}, {"Citation": "Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409\u201339. doi: 10.1152/physrev.00034.2006.", "ArticleIdList": ["10.1152/physrev.00034.2006", "17928588"]}, {"Citation": "Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7\u201336: a physiological incretin in man. Lancet. 1987;2:1300\u20134. doi: 10.1016/S0140-6736(87)91194-9.", "ArticleIdList": ["10.1016/S0140-6736(87)91194-9", "2890903"]}, {"Citation": "Han Y, Liu W, Chen L, Xin X, Wang Q, Zhang X, et al. Effective oral delivery of exenatide-zn(2+) complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy. Biomaterials. 2021;275:120944. doi: 10.1016/j.biomaterials.2021.120944.", "ArticleIdList": ["10.1016/j.biomaterials.2021.120944", "34153783"]}, {"Citation": "Brayden DJ, Alonso MJ. Oral delivery of peptides: opportunities and issues for translation. Adv Drug Deliv Rev. 2016;106:193\u20135. doi: 10.1016/j.addr.2016.10.005.", "ArticleIdList": ["10.1016/j.addr.2016.10.005", "27865345"]}, {"Citation": "Lundquist P, Khodus G, Niu Z, Thwala LN, McCartney F, Simoff I, et al. Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat. ACS Nano. 2022;16:14210\u201329. doi: 10.1021/acsnano.2c04330.", "ArticleIdList": ["10.1021/acsnano.2c04330", "PMC9527806", "35998570"]}, {"Citation": "Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. doi: 10.1016/j.addr.2016.06.005.", "ArticleIdList": ["10.1016/j.addr.2016.06.005", "27320643"]}, {"Citation": "Dahlgren D, Roos C, Johansson P, Tannergren C, Lundqvist A, Langguth P, et al. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs. Int J Pharm. 2018;547:158\u201368. doi: 10.1016/j.ijpharm.2018.05.029.", "ArticleIdList": ["10.1016/j.ijpharm.2018.05.029", "29758344"]}, {"Citation": "Kremsmayr T, Aljnabi A, Blanco-Canosa JB, Tran HNT, Emidio NB, Muttenthaler M. On the utility of chemical strategies to improve peptide gut stability. J Med Chem. 2022;65:6191\u2013206. doi: 10.1021/acs.jmedchem.2c00094.", "ArticleIdList": ["10.1021/acs.jmedchem.2c00094", "PMC9059125", "35420805"]}, {"Citation": "Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ. Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10) Pharmaceutics. 2019 doi: 10.3390/pharmaceutics11020078.", "ArticleIdList": ["10.3390/pharmaceutics11020078", "PMC6410172", "30781867"]}, {"Citation": "Buckley ST, Baekdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Ronne J, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018;10:eaar7047. doi: 10.1126/scitranslmed.aar7047.", "ArticleIdList": ["10.1126/scitranslmed.aar7047", "30429357"]}, {"Citation": "Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (Pioneer 4): a randomised, double-blind, phase 3a trial. Lancet. 2019;394:39\u201350. doi: 10.1016/S0140-6736(19)31271-1.", "ArticleIdList": ["10.1016/S0140-6736(19)31271-1", "31186120"]}, {"Citation": "He Z, Nie T, Hu Y, Zhou Y, Zhu J, Liu Z, et al. A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type ii diabetes. J Controll Release. 2020;318:86\u201397. doi: 10.1016/j.jconrel.2019.12.014.", "ArticleIdList": ["10.1016/j.jconrel.2019.12.014", "31838207"]}, {"Citation": "Stojan\u010devi\u0107 M, Pavlovi\u0107 N, Golo\u010dorbin-Kon S, Mikov M. Application of bile acids in drug formulation and delivery. Front Life Sci. 2014;7:112\u201322. doi: 10.1080/21553769.2013.879925.", "ArticleIdList": ["10.1080/21553769.2013.879925"]}, {"Citation": "Kim KS, Suzuki K, Cho H, Youn YS, Bae YH. Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport. ACS Nano. 2018;12:8893\u2013900. doi: 10.1021/acsnano.8b04315.", "ArticleIdList": ["10.1021/acsnano.8b04315", "PMC6377080", "30088412"]}, {"Citation": "Schiff ER, Small NC, Dietschy JM. Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J Clin Invest. 1972;51:1351\u201362. doi: 10.1172/JCI106931.", "ArticleIdList": ["10.1172/JCI106931", "PMC292272", "5024036"]}, {"Citation": "Slomiany BL, Aono M, Murty VL, Piasek A, Slomiany A. Effect of bile acids on the glycoprotein constituent of gastric mucus. J Appl Biochem. 1984;6:308\u201313.", "ArticleIdList": ["6536645"]}, {"Citation": "Bao X, Qian K, Yao P. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and beta-cell repair of type 2 diabetes mice. J Nanobiotechnol. 2020;18:67. doi: 10.1186/s12951-020-00619-0.", "ArticleIdList": ["10.1186/s12951-020-00619-0", "PMC7189518", "32345323"]}, {"Citation": "Dong FY, Padua GW, Wang Y. Controlled formation of hydrophobic surfaces by self-assembly of an amphiphilic natural protein from aqueous solutions. Soft Matter. 2013;9:5933\u201341. doi: 10.1039/c3sm50667c.", "ArticleIdList": ["10.1039/c3sm50667c"]}, {"Citation": "Boushra M, Tous S, Fetih G, Xue HY, Wong HL. Development of bi-polymer lipid hybrid nanocarrier (bln) to improve the entrapment and stability of insulin for efficient oral delivery. J Drug Deliv Sci Tec. 2019;49:632\u201341. doi: 10.1016/j.jddst.2019.01.007.", "ArticleIdList": ["10.1016/j.jddst.2019.01.007"]}, {"Citation": "Boushra M, Tous S, Fetih G, Korzekwa K, Lebo DB, Xue HY, et al. Development and evaluation of viscosity-enhanced nanocarrier (ven) for oral insulin delivery. Int J Pharm. 2016;511:462\u201372. doi: 10.1016/j.ijpharm.2016.07.016.", "ArticleIdList": ["10.1016/j.ijpharm.2016.07.016", "27418563"]}, {"Citation": "Bao X, Qian K, Yao P. Insulin- and cholic acid-loaded zein/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin. J Mater Chem B. 2021;9:6234\u201345. doi: 10.1039/D1TB00806D.", "ArticleIdList": ["10.1039/D1TB00806D", "34328161"]}, {"Citation": "Perinelli DR, Vllasaliu D, Bonacucina G, Come B, Pucciarelli S, Ricciutelli M, et al. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics. Eur J Pharm Biopharm. 2017;119:419\u201325. doi: 10.1016/j.ejpb.2017.07.011.", "ArticleIdList": ["10.1016/j.ejpb.2017.07.011", "28743594"]}, {"Citation": "Li M, Yu M. Development of a nanoparticle delivery system based on zein/polysaccharide complexes. J Food Sci. 2020;85:4108\u201317. doi: 10.1111/1750-3841.15535.", "ArticleIdList": ["10.1111/1750-3841.15535", "33249573"]}, {"Citation": "Jiang L, Long X, Meng Q. Rhamnolipids enhance epithelial permeability in caco-2 monolayers. Int J Pharm. 2013;446:130\u20135. doi: 10.1016/j.ijpharm.2013.02.003.", "ArticleIdList": ["10.1016/j.ijpharm.2013.02.003", "23402975"]}, {"Citation": "Frederiksen TM, Sonderby P, Ryberg LA, Harris P, Bukrinski JT, Scharff-Poulsen AM, et al. Oligomerization of a glucagon-like peptide 1 analog: bridging experiment and simulations. Biophys J. 2015;109:1202\u201313. doi: 10.1016/j.bpj.2015.07.051.", "ArticleIdList": ["10.1016/j.bpj.2015.07.051", "PMC4576320", "26340816"]}, {"Citation": "Shamekhi F, Tamjid E, Khajeh K. Development of chitosan coated calcium-alginate nanocapsules for oral delivery of liraglutide to diabetic patients. Int J Biol Macromol. 2018;120:460\u20137. doi: 10.1016/j.ijbiomac.2018.08.078.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.08.078", "30125628"]}, {"Citation": "Acik G, Karabulut HRF, Altinkok C, Karatavuk AO. Synthesis and characterization of biodegradable polyurethanes made from cholic acid and l-lysine diisocyanate ethyl ester. Polym Degrad Stabil. 2019;165:43\u20138. doi: 10.1016/j.polymdegradstab.2019.04.015.", "ArticleIdList": ["10.1016/j.polymdegradstab.2019.04.015"]}, {"Citation": "Roger E, Lagarce F, Garcion E, Benoit JP. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Controll Release. 2009;140:174\u201381. doi: 10.1016/j.jconrel.2009.08.010.", "ArticleIdList": ["10.1016/j.jconrel.2009.08.010", "19699246"]}, {"Citation": "Lopes M, Shrestha N, Correia A, Shahbazi MA, Sarmento B, Hirvonen J, et al. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin. J Controll Release. 2016;232:29\u201341. doi: 10.1016/j.jconrel.2016.04.012.", "ArticleIdList": ["10.1016/j.jconrel.2016.04.012", "27074369"]}, {"Citation": "Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377:159\u201369. doi: 10.1042/bj20031253.", "ArticleIdList": ["10.1042/bj20031253", "PMC1223843", "14505488"]}, {"Citation": "Nie T, He Z, Zhou Y, Zhu J, Chen K, Liu L, et al. Surface coating approach to overcome mucosal entrapment of DNA nanoparticles for oral gene delivery of glucagon-like peptide 1. ACS Appl Mater Interfaces. 2019;11:29593\u2013603. doi: 10.1021/acsami.9b10294.", "ArticleIdList": ["10.1021/acsami.9b10294", "31348859"]}, {"Citation": "Wu J, Zheng Y, Liu M, Shan W, Zhang Z, Huang Y. Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. ACS Appl Mater Interfaces. 2018;10:9916\u201328. doi: 10.1021/acsami.7b16524.", "ArticleIdList": ["10.1021/acsami.7b16524", "29504398"]}, {"Citation": "Wu L, Shan W, Zhang Z, Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv Drug Deliv Rev. 2018;124:150\u201363. doi: 10.1016/j.addr.2017.10.001.", "ArticleIdList": ["10.1016/j.addr.2017.10.001", "28989056"]}, {"Citation": "Beloqui A, des Rieux A, Preat V. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier. Adv Drug Deliv Rev. 2016;106:242\u201355. doi: 10.1016/j.addr.2016.04.014.", "ArticleIdList": ["10.1016/j.addr.2016.04.014", "27117710"]}, {"Citation": "Jia X, Yuan Z, Yang Y, Huang X, Han N, Liu X, et al. Multi-functional self-assembly nanoparticles originating from small molecule natural product for oral insulin delivery through modulating tight junctions. J Nanobiotechnol. 2022;20:116. doi: 10.1186/s12951-022-01260-9.", "ArticleIdList": ["10.1186/s12951-022-01260-9", "PMC8898475", "35248067"]}, {"Citation": "Fan W, Xia D, Zhu Q, Li X, He S, Zhu C, et al. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials. 2018;151:13\u201323. doi: 10.1016/j.biomaterials.2017.10.022.", "ArticleIdList": ["10.1016/j.biomaterials.2017.10.022", "29055774"]}, {"Citation": "Senduran N, Yadav HN, Vishwakarma VK, Bhatnagar P, Gupta P, Bhatia J, et al. Orally deliverable nanoformulation of liraglutide against model type 2 diabetic rat. J Drug Deliv Sci Tec. 2020;56:101513. doi: 10.1016/j.jddst.2020.101513.", "ArticleIdList": ["10.1016/j.jddst.2020.101513"]}, {"Citation": "Trott O, Olson AJ. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998;19:1639\u201362. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.", "ArticleIdList": ["10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"]}, {"Citation": "Long XW, Meng Q, Sha RY, Huang QL, Zhang GL. Two-step ultrafiltration of rhamnolipids using psu-g-peg membrane. J Membrane Sci. 2012;409:105\u201312. doi: 10.1016/j.memsci.2012.03.039.", "ArticleIdList": ["10.1016/j.memsci.2012.03.039"]}, {"Citation": "McCartney F, Perinelli DR, Tiboni M, Cavanagh R, Lucarini S, Filippo Palmieri G, et al. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae. Int J Pharm. 2021;601:120593. doi: 10.1016/j.ijpharm.2021.120593.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120593", "33857587"]}, {"Citation": "Zhang Z, Li H, Xu G, Yao P. Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids. Drug deliv. 2018;25:1224\u201333. doi: 10.1080/10717544.2018.1469685.", "ArticleIdList": ["10.1080/10717544.2018.1469685", "PMC6058709", "29791242"]}, {"Citation": "Liu H, Zhao Y, Zou Y, Huang W, Zhu L, Liu F, et al. Heparin-poloxamer hydrogel-encapsulated rhfgf21 enhances wound healing in diabetic mice. FASEB J. 2019;33:9858\u201370. doi: 10.1096/fj.201802600RR.", "ArticleIdList": ["10.1096/fj.201802600RR", "31166803"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "11"}, {"Year": "2022", "Month": "12", "Day": "7"}, {"Year": "2023", "Month": "1", "Day": "16", "Hour": "23", "Minute": "39"}, {"Year": "2023", "Month": "1", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["36647125", "PMC9843898", "10.1186/s12951-022-01743-9", "10.1186/s12951-022-01743-9"]}}], "PubmedBookArticle": []}